Untreated initial psychosis: its relation to quality of life and symptom remission in first-episode schizophrenia.
暂无分享,去创建一个
N C Andreasen | M Flaum | N. Andreasen | M. Flaum | P. Nopoulos | B. Ho | Del D. Miller | D. Miller | D Miller | B C Ho | P Nopoulos
[1] J. Waddington,et al. Psychopathology, executive (frontal) and general cognitive impairment in relation to duration of initially untreated versus subsequently treated psychosis in chronic schizophrenia , 1997, Psychological Medicine.
[2] J. Lieberman,et al. Duration of psychosis and outcome in first-episode schizophrenia. , 1992, The American journal of psychiatry.
[3] W T Carpenter,et al. The prediction of outcome in schizophrenia. I. Characteristics of outcome. , 1972, Archives of general psychiatry.
[4] W. Eaton,et al. Outcome of Schizophrenia: The Madras Longitudinal Study , 1996, The Australian and New Zealand journal of psychiatry.
[5] T. Nakajima,et al. A Longitudinal Study of Schizophrenia in Adolescence: I. The One‐ to Three‐Year Outcome , 1986, The Japanese journal of psychiatry and neurology.
[6] J. Waddington,et al. Sequential cross-sectional and 10-year prospective study of severe negative symptoms in relation to duration of initially untreated psychosis in chronic schizophrenia , 1995, Psychological Medicine.
[7] W. Dixon,et al. Schizophrenia--a follow-up study of results of treatment. , 1976, Archives of general psychiatry.
[8] J. Lindenmayer,et al. Outcome Predictors in Acute Schizophrenia: Prospective Significance of Background and Clinical Dimensions , 1987, The Journal of nervous and mental disease.
[9] R. Bilder,et al. Symptomatic and neuropsychological components of defect states. , 1985, Schizophrenia bulletin.
[10] J. Fleiss,et al. The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance. , 1976, Archives of general psychiatry.
[11] C. Mihalopoulos,et al. EPPIC: an evolving system of early detection and optimal management. , 1996, Schizophrenia bulletin.
[12] J. Rabinowitz,et al. Relationship between type of insurance and care during the early course of psychosis. , 1998, The American journal of psychiatry.
[13] A. Korten,et al. “Mental health literacy”: a survey of the public's ability to recognise mental disorders and their beliefs about the effectiveness of treatment , 1997, The Medical journal of Australia.
[14] W. Lo,et al. A Ten-Year Follow-up Study of Chinese Schizophrenics in Hong Kong , 1977, British Journal of Psychiatry.
[15] R J Wyatt,et al. Neuroleptics and the natural course of schizophrenia. , 1991, Schizophrenia bulletin.
[16] T. Crow,et al. II. A Randomised Controlled Trial of Prophylactic Neuroleptic Treatment , 1986, British Journal of Psychiatry.
[17] H. Blum,et al. Five-year Outcome and Prognosis in Schizophrenia: A Report from the London Field Research Centre of the International Pilot Study of Schizophrenia , 1987, British Journal of Psychiatry.
[18] N. Andreasen,et al. Premorbid adjustment as a predictor of phenomenological and neurobiological indices in schizophrenia , 1993, Schizophrenia Research.
[19] F. Sainfort,et al. Judgments of quality of life of individuals with severe mental disorders: Patient self-report versus provider perspectives. , 1996, The American journal of psychiatry.
[20] J. McEvoy,et al. Predictors of therapeutic response to haloperidol in acute schizophrenia. , 1991, Psychopharmacology bulletin.
[21] N C Andreasen,et al. Two-year outcome in first-episode schizophrenia: predictive value of symptoms for quality of life. , 1998, The American journal of psychiatry.
[22] J. O. Johannessen,et al. Early detection and intervention with schizophrenia: rationale. , 1996, Schizophrenia bulletin.
[23] H. Hwu,et al. Negative Symptoms at Discharge and Outcome in Schizophrenia , 1995, British Journal of Psychiatry.
[24] M. Angermeyer,et al. Relatives' beliefs about the causes of schizophrenia , 1996, Acta psychiatrica Scandinavica.
[25] P. May,et al. Treatment of Schizophrenia , 1965, British Journal of Psychiatry.
[26] Alogia, attentional impairment, and inappropriate affect: Their status in the dimensions of schizophrenia , 1993 .
[27] T. McGlashan,et al. Sustained remission in drug-free schizophrenic patients. , 1987, The American journal of psychiatry.
[28] E. Lindström,et al. Symptoms at index admission as predictor for 1‐5 year outcome in schizophrenia , 1996, Acta psychiatrica Scandinavica.
[29] J. Goldstein. Gender differences in the course of schizophrenia. , 1988, The American journal of psychiatry.
[30] A. Riecher-Rössler,et al. The Influence of Age and Sex on the Onset and Early Course of Schizophrenia , 1993, British Journal of Psychiatry.
[31] H. Möller,et al. Outcome in schizophrenic and similar paranoid psychoses. , 1982, Schizophrenia bulletin.
[32] J. Waddington,et al. Untreated psychosis and long-term outcome in schizophrenia. , 1998, Schizophrenia bulletin.
[33] Anthony F Jorm,et al. Mental health literacy , 2000, British Journal of Psychiatry.
[34] R. Wyatt,et al. Long-term morbidity associated with delayed treatment of first admission schizophrenic patients: a re-analysis of the Camarillo State Hospital data , 1997, Psychological Medicine.
[35] Tyrone D. Cannon,et al. Course of treatment response in first-episode and chronic schizophrenia. , 1996, The American journal of psychiatry.
[36] C. Frith,et al. The Outcome of Severe Acute Schizophrenic Illnesses After One Year , 1979, British Journal of Psychiatry.
[37] J. Strauss,et al. Prediction of outcome in schizophrenia. III. Five-year outcome and its predictors. , 1977, Archives of general psychiatry.
[38] R. Wyatt. The Dopamine Hypothesis: Variations on a Theme , 1985 .
[39] N. Andreasen,et al. The Iowa prospective longitudinal study of recent-onset psychoses. , 1992, Schizophrenia bulletin.
[40] D. Pickar,et al. National Institute of Mental Health longitudinal study of chronic schizophrenia. Prognosis and predictors of outcome. , 1991, Archives of general psychiatry.
[41] W. Carpenter. Medication-Free Research and Patient Safety , 1998 .
[42] J. Lieberman,et al. Gender differences in onset of illness, treatment response, course, and biologic indexes in first-episode schizophrenic patients. , 1995, The American journal of psychiatry.
[43] P. Liddle. The Symptoms of Chronic Schizophrenia , 1987, British Journal of Psychiatry.
[44] W. Dixon,et al. Schizophrenia--a follow-up study of results of treatment. I. Design and other problems. , 1976, Archives of general psychiatry.
[45] W. Carpenter. The risk of medication-free research. , 1997, Schizophrenia bulletin.
[46] J. Schwartz,et al. The natural course of schizophrenia: a review of first-admission studies. , 1992, Schizophrenia bulletin.
[47] N C Andreasen,et al. The Distinction of Positive and Negative Symptoms , 1991, British Journal of Psychiatry.
[48] J. Addington,et al. Premorbid functioning, cognitive functioning, symptoms and outcome in schizophrenia. , 1993, Journal of psychiatry & neuroscience : JPN.
[49] J. Bailer,et al. Premorbid adjustment as predictor of outcome in schizophrenia: results of a prospective study , 1996, Acta psychiatrica Scandinavica.
[50] J. Kane,et al. Outcome study of first-episode psychosis. I: Relapse rates after 1 year. , 1986, The American journal of psychiatry.
[51] N C Andreasen,et al. The Comprehensive Assessment of Symptoms and History (CASH). An instrument for assessing diagnosis and psychopathology. , 1992, Archives of general psychiatry.
[52] W. Dixon,et al. Schizophrenia. A follow-up study of the results of five forms of treatment. , 1981, Archives of general psychiatry.
[53] L. Linn,et al. Chronic mental patients: the quality of life issue. , 1982, The American journal of psychiatry.
[54] E. Bromet,et al. The Suffolk County Mental Health Project: demographic, pre-morbid and clinical correlates of 6-month outcome , 1996, Psychological Medicine.
[55] A. Awad. Quality of life rediscovered: implications for clinical outcome and health economics in schizophrenia. , 1997, Journal of psychiatry & neuroscience : JPN.
[56] R. Wyatt. Early intervention for schizophrenia: Can the course of the illness be altered? , 1995, Biological Psychiatry.